Key Points The major indices are pushing aggressively higher on hopes for trade deals. All of which is helping to fuel upside ...

Trading set to begin Tuesday, April 8 under new ticker“SLSN” ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: ...

In a notable financial adjustment, Mitchell Capital Management Co. reduced its stake in NVIDIA Co. (NASDAQ: NVDA) by 0.9% during the fourth quarter, as disclosed in its recent filing with the ...

As a result, the Company expects that the last trading day of its common stock on the Nasdaq Capital Market will be on or about April 21, 2025. Following a thorough and extensive evaluation ...

PURCHASE, N.Y. - Cognition Therapeutics, Inc. (NASDAQ:CGTX), a biopharmaceutical company focused on neurodegenerative disorders with a current market capitalization of $17 million, has been ...

As we settle into a new year, the global initial public offering landscape presents a fascinating tapestry of challenges and opportunities.

(BSGM) ("BioSig” or the "Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, is pleased to announce that its common stock ...

The Company’s common stock will continue to be listed and traded on The Nasdaq Capital Market. Headquartered in Houston, Texas, Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company ...

announced its transfer of stock listing from The Nasdaq Global Select Market to The Nasdaq Capital Market, effective as the business opens on Monday. The biotechnology firm, specializing in ...

Commencing with the opening of trading on the Nasdaq Capital Market on March 17, 2025, the Company’s common stock will trade on a post-split basis under the same symbol ADTX. The reverse stock ...